Skip to main content

International Journal of Clinical Oncology

Ausgabe 12/2020

Inhalt (22 Artikel)

Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer

  • Original Article

Nadiye Akdeniz, Mehmet Küçüköner, Muhammet Ali Kaplan, Zuhat Urakçı, Oğur Karhan, Yasin Sezgin, Erkan Bilen, Senar Ebinç, Fatma Teke, Şahin Laçin, Özkan Alan, Özlem Ercelep, Abdurrahman Işıkdoğan, Perran Fulden Yumuk

High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor

  • Original Article

Ting Lei, Lijuan Yin, Hongying Zhang, Bing Wei, Huijiao Chen, Tianjie Pu, Libo Yang, Feng Ye, Zhang Zhang, Hong Bu

A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302)

  • Open Access
  • Original Article

Shigeyuki Tamura, Hirokazu Taniguchi, Kazuhiro Nishikawa, Hiroshi Imamura, Junya Fujita, Atsushi Takeno, Jin Matsuyama, Yutaka Kimura, Junji Kawada, Motohiro Hirao, Masashi Hirota, Kazumasa Fujitani, Yukinori Kurokawa, Daisuke Sakai, Hisato Kawakami, Toshio Shimokawa, Taroh Satoh

YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2

  • Original Article

Qingli Bie, Xiaozhe Li, Shiqi Liu, Xiao Yang, Zhenwen Qian, Rou Zhao, Xiaobei Zhang, Bin Zhang

FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study

  • Original Article

Priscilla de Albuquerque Ribeiro Gondinho, Paulo Goberlânio de Barros Silva, Mário Roberto Pontes Lisboa, Bruno Almeida Costa, Duílio Reis da Rocha Filho, Markus Andret Cavalcante Gifoni, Marcos Venicio Alves Lima, Roberto César Pereira Lima Junior, Mariana Lima Vale

Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan

  • Original Article

Ryo Ohta, Takeshi Yamada, Keisuke Hara, Takuma Iwai, Kohji Tanakaya, Keiichiro Ishibashi, Kazuhiko Yoshimatsu, Chihiro Kosugi, Masahiro Tsubaki, Hideo Nakajima, Masatoshi Oya, Hiroshi Yoshida, Keiji Koda, Hideyuki Ishida

Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma

  • Original Article

Kazunori Tokuda, Yuji Morine, Yu Saito, Shinichiro Yamada, Katsuki Miyazaki, Shoko Yamashita, Shohei Okikawa, Tetsuya Ikemoto, Satoru Imura, Mitsuo Shimada

Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index

  • Open Access
  • Original Article

Takahiro Osawa, John T. Wei, Takashige Abe, Michitaka Honda, Shuhei Yamada, Jun Furumido, Hiroshi Kikuchi, Ryuji Matsumoto, Kazushi Hirakawa, Yasuyuki Sato, Yoshihiro Sasaki, Toru Harabayashi, Norikata Takada, Keita Minami, Hiroshi Tanaka, Ken Morita, Akira Kashiwagi, Naoto Miyajima, Tomoshige Akino, Sachiyo Murai, Yoichi M. Ito, Shunichi Fukuhara, Katsuhiko Ogasawara, Nobuo Shinohara

Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases

  • Original Article

Rei Kamitani, Kazuhiro Matsumoto, Toshikazu Takeda, Ryuichi Mizuno, Mototsugu Oya

The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

  • Original Article

Yoichiro Tohi, Takuma Kato, Ryuji Matsumoto, Nobuo Shinohara, Kenichiro Shiga, Akira Yokomizo, Masaki Nakamura, Haruki Kume, Koji Mitsuzuka, Hiroshi Sasaki, Shin Egawa, Masafumi Matsumura, Katsuyoshi Hashine, Junichi Inokuchi, Masatoshi Eto, Haruki Baba, Tomohiko Ichikawa, Hidefumi Kinoshita, Tadashi Matsuda, Yoshiyuki Kakehi, Mikio Sugimoto

Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer

  • Original Article

Xiao-xiao Guo, Run-qi Guo, Hui-min Hou, Xuan Wang, Jian-ye Wang, Ming Liu

Effect of general self-efficacy on promoting health-related quality of life during recovery from radical prostatectomy: a 1-year prospective study

  • Original Article

Kansuke Kawaguchi, Hisashi Kawazoe, Toshihiko Sakurai, Hayato Nishida, Hidenori Kanno, Sei Naito, Tomoyuki Kato, Tsuneo Konta, Norihiko Tsuchiya, Wakako Sato

Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer

  • Original Article

Masashi Kato, Akihiro Hirakawa, Yumiko Kobayashi, Akiyuki Yamamoto, Yushi Naito, Kosuke Tochigi, Tomoyasu Sano, Shohei Ishida, Yasuhito Funahashi, Takashi Fujita, Yoshihisa Matsukawa, Ryohei Hattori, Toyonori Tsuzuki

Diagnostic criteria of sentinel lymph node micrometastasis or macrometastasis based on tissue rinse liquid-based cytology in gynecological cancer

  • Original Article

Hiroko Matsumiya, Yukiharu Todo, Hiroyuki Yamazaki, Ryutaro Yamada, Kaoru Minowa, Tomohiko Tsuruta, Hiroyuki Kurosu, Shinichiro Minobe, Hidenori Kato, Hiroaki Suzuki, Kiyomi Taira, Katsushige Yamashiro

Daratumumab therapy for relapsed or refractory multiple myeloma: a single-center retrospective study

  • Original Article

Kazutaka Sunami, Hiroyuki Murakami, Hisashi Tagashira, Hiroko Ueda, Takashi Moriyama, Tatsunori Ishikawa, Takanori Yoshioka, Masanori Makita

Accuracy of histological grades from intraoperative frozen-section diagnoses of soft-tissue tumors

  • Original Article

Shinji Miwa, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Kentaro Igarashi, Kaoru Tada, Takashi Higuchi, Hirotaka Yonezawa, Sei Morinaga, Yoshihiro Araki, Yohei Asano, Hiroko Ikeda, Takayuki Nojima, Hiroyuki Tsuchiya

Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3–4, 2020

  • Letter to the Editor

Wataru Fukuokaya, Takahiro Kimura, Fumihiko Urabe, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yusuke Koike, Hiroshi Sasaki, Kenta Miki, Shin Egawa

Neu im Fachgebiet Onkologie

Körperlich fitte Krebskranke leben länger

Krebspatienten, auch und vor allem solche in fortgeschrittenen Stadien, profitieren offenbar von guter körperlicher Verfassung. Hohe Muskelkraft und kardiorespiratorische Fitness sind laut Ergebnissen einer Metaanalyse mit geringerer Mortalität assoziiert.

Kein (großer) Schutz vor Kolorektalkarzinom-Rezidiven durch ASS

Die erste Phase-3-Studie zum Nutzen von ASS in der adjuvanten Therapie des kolorektalen Karzinoms ist negativ verlaufen. Das abschließende Urteil über eine Sekundärprävention mit ASS ist trotzdem noch nicht gefallen.

Frühe CLL-Therapie: BTK-Hemmer verlängert EFS und PFS, aber nicht OS

Auch nach sechs Jahren ergibt sich kein Überlebensvorteil einer Therapie mit dem BTK-Hemmer Ibrutinib für Menschen mit frühem CLL-Stadium und erhöhtem Progressionsrisiko. Die Progressionsrate wird mit der Behandlung jedoch um über 80% gesenkt.

Adjuvantes Atezolizumab ohne Nutzen bei frühem TNBC

Patientinnen mit frühem triple-negativem Brustkrebs profitieren nach der Operation offenbar nicht von einer Zugabe des PD-L1-Hemmers Atezolizumab zur adjuvanten Standardchemotherapie. Die Studie, die das untersucht hat, wurde vorzeitig abgebrochen. Was könnte die schlechte Wirksamkeit erklären?

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.